LVW Advisors LLC trimmed its position in Relx Plc (NYSE:RELX – Free Report) by 4.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,930 shares of the technology company’s stock after selling 624 shares during the quarter. LVW Advisors LLC’s holdings in Relx were worth $587,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. Versant Capital Management Inc acquired a new position in shares of Relx during the 4th quarter worth $31,000. Private Trust Co. NA raised its holdings in Relx by 119.9% during the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after purchasing an additional 566 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Relx in the 3rd quarter worth about $125,000. Grove Bank & Trust lifted its stake in Relx by 10.2% in the third quarter. Grove Bank & Trust now owns 3,758 shares of the technology company’s stock valued at $178,000 after buying an additional 348 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in Relx by 33.9% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 3,952 shares of the technology company’s stock valued at $188,000 after acquiring an additional 1,000 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.
Relx Trading Up 0.6 %
NYSE RELX opened at $48.18 on Tuesday. Relx Plc has a 1 year low of $40.25 and a 1 year high of $48.91. The company has a fifty day moving average price of $46.44 and a 200-day moving average price of $46.59.
Analysts Set New Price Targets
Read Our Latest Stock Report on RELX
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- What Are Dividend Achievers? An Introduction
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What is the Nikkei 225 index?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- 3 Fintech Stocks With Good 2021 Prospects
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.